Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.
Nagata Y, Kageyama S, Ishikawa T, Kokura S, Okayama T, Abe T, Murakami M, Otsuka K, Ariyoshi T, Kojima T, Taniguchi K, Kobayashi S, Shimada H, Yajima S, Suzuki T, Hirano S, Tsuchikawa T, Shichinohe T, Ueda S, Kanetaka K, Yoneda A, Wada H, Doki Y, Yamaue H, Katsuda M, Ohi M, Yasuda H, Kondo K, Kataoka M, Kodera Y, Koike M, Shiraishi T, Miyahara Y, Goshima N, Fukuda E, Yamaguchi K, Sato E, Ikeda H, Yamada T, Osako M, Hirai K, Miyamoto H, Watanabe T, Shiku H. Nagata Y, et al. Among authors: yamada t. Cancer Immunol Immunother. 2022 Nov;71(11):2743-2755. doi: 10.1007/s00262-022-03194-5. Epub 2022 Apr 16. Cancer Immunol Immunother. 2022. PMID: 35429246 Free PMC article. Clinical Trial.
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.
Kageyama S, Wada H, Muro K, Niwa Y, Ueda S, Miyata H, Takiguchi S, Sugino SH, Miyahara Y, Ikeda H, Imai N, Sato E, Yamada T, Osako M, Ohnishi M, Harada N, Hishida T, Doki Y, Shiku H. Kageyama S, et al. Among authors: yamada t. J Transl Med. 2013 Oct 5;11:246. doi: 10.1186/1479-5876-11-246. J Transl Med. 2013. PMID: 24093426 Free PMC article. Clinical Trial.
Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression.
Kobayashi M, Mizuno S, Murata Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Ii N, Yamakado K, Inoue H, Shiraishi T, Yamada T, Isaji S. Kobayashi M, et al. Among authors: yamada t. Pancreas. 2014 Apr;43(3):350-60. doi: 10.1097/MPA.0000000000000059. Pancreas. 2014. PMID: 24622063 Free PMC article.
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.
Urakawa S, Yamasaki M, Goto K, Haruna M, Hirata M, Morimoto-Okazawa A, Kawashima A, Iwahori K, Makino T, Kurokawa Y, Yamada T, Mori M, Doki Y, Wada H. Urakawa S, et al. Among authors: yamada t. Cancer Immunol Immunother. 2019 Aug;68(8):1341-1350. doi: 10.1007/s00262-019-02366-0. Epub 2019 Jul 19. Cancer Immunol Immunother. 2019. PMID: 31324947 Free PMC article.
OSK-0028 in Patients With Esophageal Cancer Undergoing Esophagectomy: A Double-blind, Randomised Controlled Trial.
Yamashita K, Miyazaki Y, Nakatani D, Masuike Y, Tanaka K, Sugimura K, Makino T, Shiraishi O, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Kimura Y, Araki H, Yamada T, Yasuda T, Yano M, Eguchi H, Doki Y. Yamashita K, et al. Among authors: yamada t. Anticancer Res. 2021 Aug;41(8):3875-3884. doi: 10.21873/anticanres.15182. Anticancer Res. 2021. PMID: 34281849 Clinical Trial.
Manserin as a novel histochemical neuroendocrine marker in prostate cancer.
Nishikawa K, Soga N, Ishii K, Kato M, Iwamoto Y, Hori Y, Etoh M, Ohkawara T, Yamada T, Uchida K, Kise H, Arima K, Narita M, Shiraishi T, Sugimura Y. Nishikawa K, et al. Among authors: yamada t. Urol Oncol. 2013 Aug;31(6):787-95. doi: 10.1016/j.urolonc.2011.06.010. Epub 2011 Jul 30. Urol Oncol. 2013. PMID: 21803620
Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K. Yokoyama S, et al. Among authors: yamada t. Clin Breast Cancer. 2018 Apr;18(2):e157-e165. doi: 10.1016/j.clbc.2017.05.013. Epub 2017 Jun 29. Clin Breast Cancer. 2018. PMID: 28735677
Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy.
Yamasaki T, Kamba T, Kanno T, Inoue T, Shibasaki N, Arakaki R, Yamada T, Kondo K, Kamoto T, Nishiyama H, Ogawa O, Nakamura E. Yamasaki T, et al. Among authors: yamada t. Cancer Sci. 2012 Nov;103(11):2027-37. doi: 10.1111/j.1349-7006.2012.02412.x. Epub 2012 Oct 10. Cancer Sci. 2012. PMID: 22931246 Free PMC article.
12,301 results
You have reached the last available page of results. Please see the User Guide for more information.